drugset / Trial / NCT02772289
Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is to investigate the efficacy and safety of perinatal tissue mesenchyme stem cells treatment on the appearance of a caesarean scar as compared to a similar untreated scar.
Timeline
- Start
- 2016-11
- Primary completion
- 2018-09
- Completion
- 2019-03
Outcome
Missed primary endpoint
paper No significant difference was found between-group in the mean scores for VSS at the sixth month. PMID 32586366 ↗
Publications
- Fan D, Zeng M, Xia Q, Wu S, Ye S, Rao J, Lin D, Zhang H, Ma H, Han Z, Guo X, Liu Z. Efficacy and safety of umbilical cord mesenchymal stem cells in treatment of cesarean section skin scars: a randomized clinical trial. Stem Cell Res Ther. 2020 Jun 25;11(1):244. doi: 10.1186/s13287-020-01695-7.
- Fan D, Xia Q, Wu S, Ye S, Liu L, Wang W, Guo X, Liu Z. Mesenchymal stem cells in the treatment of Cesarean section skin scars: study protocol for a randomized, controlled trial. Trials. 2018 Mar 2;19(1):155. doi: 10.1186/s13063-018-2478-x.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Perinatal Tissue Mesenchyme Stem Cells | Unknown | 3 cells | Other |
| Subject | Perinatal Tissue Mesenchyme Stem Cells | Unknown | 6 cells | Other |
Indications
No indication recorded.